Auther | Year | Country | Genotype method | SOC | Ethnicity | Cancer type | Case | Control | HWE | NOS | ||||
TT | AT | AA | TT | AT | AA | P-value | ||||||||
Wang [9] | 2017 | China | PCR | HB | Chinese | BC | 317 | 207 | 36 | 338 | 202 | 42 | 0.13 | 8 |
Fard [10] | 2018 | Iran | RFLP-PCR | PB | Iranian | BC | 96 | 65 | 42 | 106 | 74 | 23 | 0.08 | 6 |
Chang [17] | 2014 | china | PCR | HB | Chinese | RCC | 29 | 48 | 15 | 285 | 191 | 104 | <0.01 | 5 |
Bau [20] | 2011 | china | RFLP-PCR | HB | Chinese | OC | 363 | 193 | 64 | 306 | 206 | 108 | <0.01 | 8 |
Hsu [12] | 2013 | china | RT-PCR | HB | Chinese | HCC | 166 | 93 | 39 | 152 | 98 | 48 | <0.01 | 5 |
lin [13] | 2014 | china | RFLP-PCR | HB | Chinese | GC | 188 | 135 | 35 | 192 | 133 | 33 | 0.16 | 5 |
liu [11] | 2011 | China | RFLP-PCR | HB | Chinese | BC | 745 | 410 | 77 | 694 | 472 | 111 | 0.02 | 5 |
Sugie [16] | 2013 | japan | RFLP-PCR | HB | Japanese | PC | 60 | 63 | 11 | 25 | 42 | 19 | 0.86 | 6 |
Wang [27] | 2014 | China | RFLP-PCR | HB | Chinese | ESCC | 259 | 143 | 25 | 221 | 166 | 40 | 0.28 | 5 |
chang [17] | 2013 | China | RFLP-PCR | HB | Chinese | UUTC | 140 | 65 | 13 | 303 | 224 | 53 | 0.21 | 5 |
Yang [14] | 2010 | China | RFLP-PCR | HB | Chinese | CRC | 216 | 117 | 29 | 179 | 120 | 63 | <0.01 | 7 |
Tsou [21] | 2011 | China | RFLP-PCR | HB | Chinese | NPC | 109 | 55 | 12 | 86 | 57 | 33 | <0.01 | 5 |
Zhang [15] | 2014 | chian | RFLP-PCR | HB | Chinese | GC | 239 | 134 | 39 | 210 | 136 | 66 | <0.01 | 6 |
bau [18] | 2011 | chian | RFLP-PCR | HB | Chinese | bladder cancer | 231 | 122 | 22 | 198 | 142 | 35 | 0.2 | 6 |
wu [19] | 2011 | chian | RFLP-PCR | HB | Chinese | PC | 163 | 75 | 12 | 254 | 196 | 50 | 0.18 | 6 |
Wang [22] | 2013 | chian | RFLP-PCR | HB | Chinese | leukemia | 167 | 86 | 13 | 140 | 99 | 27 | 0.14 | 6 |